Down-regulation of transforming growth factor beta-2 expression is associated with the reduction of cyclosporin induced gingival overgrowth in rats treated with roxithromycin: An experimental study

BMC Oral Health

Volumn 9, Issue 1, 2009, Pages

  Condé, Simone Aparecida Probst ^a   Bastos, Marcus Gomes ^a   Vieira, Beatriz Julio ^a   Aarestrup, Fernando Monteiro ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; ROXITHROMYCIN; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DOWN REGULATION; GINGIVA OVERGROWTH; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; RANDOMIZATION; RAT; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; CYCLOSPORINE; DOWN-REGULATION; GINGIVAL OVERGROWTH; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; ROXITHROMYCIN; TRANSFORMING GROWTH FACTOR BETA2;

EID: 74549140287     PISSN: None     EISSN: 14726831     Source Type: Journal    
DOI: 10.1186/1472-6831-9-33     Document Type: Article

References (33)

1. Initial observation that cyclosporine-A induces gingival enlargement in man. EM Rateitschak-Pluss A Hefti R Löertscher G Thiel, J Clin Periodontol 1983 10 237 246 10.1111/j.1600-051X.1983.tb01272.x 6575979
2. Cyclosporin therapy. TD Daley GP Wysocki, J Periodontol 1984 55 708 712 6335173
3. Cyclosporine. BD Kahan, N Engl J Med 1989 321 1725 1738 2687689
4. Cyclosporin and the gingival tissues. RA Seymour DJ Jacobs, J Clin Periodontol 1992 19 1 11 10.1111/j.1600-051X.1992.tb01140.x 1732303
5. Fibrous hyperplasia of gingival: a side effect of cyclosporin-A therapy. GP Wisocki HA Gretzinger A Laupacis, et al. Oral Surg Oral Med Oral Pathol 1983 55 274 278 10.1016/0030-4220(83)90327-4 6572880
6. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. TD Daley GP Wysocki C Day, Oral Surg Oral Med Oral Path 1986 62 417 421 10.1016/0030-4220(86)90291-4 3464914
7. The comparative effectof azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. RA Seymour DG Smith SR Rogers, J Clin Periodontol 1987 14 610 613 10.1111/j.1600-051X.1987.tb01524.x 3320101
8. Cyclosporine-A induced gingival overgrowth in renal transplant children. B Wondimu G Dahllof U Berg, et al. Scand J Dent Res 1993 101 282 286 8248730
9. Evaluation of cyclosporine induced gingival overgrowth in the pediatric transplant patient. SD Allman AG Mcwhorter NS Seale, Pediatr Dent 1994 16 36 40 8015940
10. Prevalence and severity of cyclosporine and nifedipine.-induced gingival overgrowth. JM Thomason RA Seymour N Rice, J Clin Periodontol 1993 20 37 40 10.1111/j.1600-051X.1993.tb01757.x 8421114
11. Nifedipine aggravates cyclosporine-A induced gingival hyperplasia. A Bökenkamp B Bohnhorst C Beier, et al. Pediatr Nephrol 1994 181 185 10.1007/BF00865474 8018496
12. Gingival overgrowth induced by nifedipine and cyclosporin A. F O'Valle F Mesa J Aneiros, et al. J Clin Periodontol 1995 22 591 597 10.1111/j.1600-051X. 1995.tb00810.x 8583014
13. Cyclosporin-and nifedipine-induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, and HLA- antigens. V Margiotta I Pizzo G Pizzo, et al. J Oral Pathol Med 1996 25 128 134 10.1111/j.1600-0714.1996.tb00207.x 8860144
14. Gingival fibroblast response to cyclosporin A and transforming growth factor beta 1. JA James CR Irwin GJ Linden, J Periodontol Res 1998 33 40 48
15. Pathogenesis of fibrosis: Role of TGF and CTGF. H Ihn, Curr Opin Rheumatol 2002 14 681 685 10.1097/00002281-200211000-00009 12410091
16. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow. JM Vieira Jr IL Noronha DM Malheiros EA Burdmann, Transplantation 1999 68 1746 1753 10.1097/00007890-199912150-00019 10609952
17. TGF- isoforms and TGF-receptors in drug-induced gingival and hereditary gingival overgrowth. HJ Wrigth ILC Chapple JB Matthews, J Oral Pathol 2001 30 281 289 10.1034/j.1600-0714.2001.300505.x (Pubitemid 32663007)
18. Efficacy of growth factors in the accelerated closure of interstices in explanted meshed human skin grafts. PD Smith M Polo PM Soler JS McClintock SP Maggi YJ Kim F Ko CM Robson, J Burn Care Rehabil 2000 21 5 9 10.1097/00004630-200021010-00003 10661532
19. TGF-beta pathobiology in the eye. S Saika, Lab Invest 2006 86 2 106 115 10.1038/labinvest.3700375 16341020
20. Determination of active TGF-2 in aqueous humor prior to and following cryopreservation. P Maier A Broszinski U Heiznann D Boehringer T Reinhard, Molecular Vision 2006 12 1477 1482 10.1016/0042-6989(72)90173-3 17167403
21. Roxithromycin inhibits transforming growth factor- production by cultured human mesangial cells. H Yamabe M Shimada M Kaizuka R Kumasaka R Murakami T Fujita N Nakamura H Osawa K Okumura, Nephrology 2006 11 524 530 10.1111/j.1440-1797.2006.00695.x 17199791
22. Roxithromycin reduces cyclosporine-induced gingival hyperplasia in renal transplant patients. SAP Conde FM Aarestrup BJ Vieira MG Bastos, Transplantation Proceedings 2008 40 1435 1438 10.1016/j.transproceed.2008.04.012 18589124
23. The pathogenesis of drug induced gingival overgrowth. RA Seymour JM Thomason JS Ellis, J Clin Periodontol 1996 23 165 175 10.1111/j.1600-051X.1996. tb02072.x 8707974
24. Pharmacology of immunosuppressive medications used in renal diseases and transplantation. AM De Mattos AJ Olyaei WM Bennett, Am J Kidney Dis 1996 28 631 667 10.1016/S0272-6386(96)90246-2 9158202
25. Growth factors and proliferation of cultured rat gingival cells in response to cyclosporin A. T Yoshida J Nagata A Yamane, J Periodont Res 2005 40 11 19 10.1111/j.1600-0765.2004.00762.x 15613074
26. Salivary proteins and cytokines in drug-induced gingival overgrowth. S Ruhl S Hamberger R Betz T Sukkar G Schmalz RA Seymour KA Hiller JM Thomason, J Dent Res 2004 83 4 322 326 10.1177/154405910408300410 15044507
27. Purification and properties of a type transforming growth factor from bovine bovine kidney. AB Roberts MA Anzano CA Meyers J Wideman R Blacher YC Pan S Stein SR Lehrman JM Smith LC Lamb, Biochemistry 1983 22 5692 5698 10.1021/bi00294a002 6607069
28. Comparison of azithromycin and oral hygiene program in the treatment of cyclosporin-induced gingival hyperplasia. VL Ramalho HJ Ramalho JP Cipullo R Azoubel EA Burdmann, Ren Fail 2007 29 265 70 10.1080/08860220701263580 17497438
29. Immunohistochemical localization of transforming growth factor b, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. K Saito S Mori M Iwakura S Sakamoto, J Periodont Res 1996 31 545 555 10.1111/j.1600-0765.1996.tb00519.x 8971653
30. Improvement in cyclosporine associated gingival hiperplasia with azithromycin therapy. E Wahlstrom JV Zamora S Teichman, N Engl J Med 1995 332 11 753 754 10.1056/NEJM199503163321116 7854392
31. The cell biology of trasnsforming growth factor-. JÁ Barnard RM Lyons HL Moses, Biochim Biophys Acta 1990 1032 79 87 2194569
32. Treatment of cyclosporin-induced gingival hyperplasia with azithromycin. E Gámez M Snchez-Nũes JE Snchez C Corte S Aguado C Portal J Baltar J Alvarez-Grande, Nephrol Dial Transplant 1997 12 2694 2697 10.1093/ndt/12.12. 2694 9430874 (Pubitemid 27520697)
33. Effect of antibiotic treatment azithromycin on cyclosporine Ainduced gingival hyperplasia among renal transplant recipients. GH Wirnsberger R Pfragner A Mauric R Zach A Bogiatzis H Holzer, Transplant Proc 1998 30 2117 2119 10.1016/S0041-1345(98)00558-2 9723411